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Abstract 
Since July 2013 it has become evident that medicinal plant material may be contaminated by 
pyrrolizidine alkaloid (PA)-containing weeds e.g. Senecio species (BFR, 2013; MULDER et al. 2015). 
This is a big challenge for growers and manufacturers with regard to the precise qualitative and 
quantitative determination of the contaminants as well as to their reduction. Already at an early 
stage, the German herbal medicinal products industry has taken measures in order to avoid and/or 
reduce PA contamination as far as possible. These measures consist e.g. in the collection of data, 
participation in research projects and the adoption of a „Code of Practice” (BAH AND BPI, 2015) that 
was elaborated together with herb growers. This document provides a framework for the imple-
mentation of individual measures in pharmaceutical companies along the entire process chain 
from cultivation up to control and release of the finished product.  
The EMA Herbal Medicinal Products Committee (HMPC) had published its final „Public Statement” 
on the assessment of PA-containing herbal medicinal products in December 2014 (EMA/HMPC, 
2014). It concludes that the exposure to PA should be kept as low as possible and sets a daily limit 
of 0.35 µg PA. E.g. in Germany, the health authority (BFARM, 2016) implemented a transitional limit 
of 1.0 µg PA daily, considering the fact that implementation of a lower limit for all medicinal plants 
did not seem realistic. Industry had argued that due to worldwide cultivation and season-
dependent production processes, a short-term reduction of PA contamination at all sites is impos-
sible. 
The complexity of the problems requires an intensive co-operation of agriculture, industry, health 
authorities and scientific societies. In this respect, ongoing and new research projects on the oc-
currence and reduction of PA-containing weeds as well as the toxicological assessment of PA play 
an important role. The target is a continuous and sustainable further reduction of PA contamina-
tion and to guarantee further production of products which are safe and of high and consistent 
quality. 
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